文献速递细菌感染、耐药与抗菌药物医院感染防控

设计更好的系统以应对脓毒症与抗菌药物管理的张力

Designing better systems to navigate the sepsis-antimicrobial stewardship tension.
PubMed 文献 · Lancet Infect Dis · 2025-04-10

该文为个人观点文章,探讨人员、环境、工具、技术和任务等系统因素如何影响脓毒症管理与抗菌药物管理之间的张力。作者借用患者安全系统工程倡议,通过案例说明组织压力、诊断工具不足和社会文化因素导致想象工作与实际工作之间的差距。作者认为应设计更好的系统而非归咎个人,并主张各学科采用系统思维设计干预措施。

要点

  • 脓毒症需及时抗菌治疗以降低死亡率,但高收入国家脓毒症死亡率仍较高,指南质量与临床应用存在差距。
  • 抗菌药物耐药上升威胁感染控制疗效,凸显脓毒症管理与抗菌药物管理之间的张力。
  • 组织压力、诊断工具不足和社会文化因素驱动想象工作与实际工作之间的差距,形成妨碍指南依从的潜在安全风险。

核心结论

  • 作者认为解决脓毒症和抗菌药物耐药需要整体系统方法,政策制定者、临床医生、研究者和药物开发者等每个学科都应在设计干预措施时采用系统思维。

研究设计与样本

  • 个人观点文章,使用患者安全系统工程倡议,通过案例研究探讨系统因素对脓毒症与抗菌药物管理张力的影响。

主要发现

  • 高收入国家脓毒症死亡率仍较高,表明指南质量、可用性与实际应用之间存在差距。
  • 组织压力、诊断工具不足和社会文化因素驱动想象工作与实际工作之间的差距。
  • 这些潜在安全风险妨碍指南依从并导致非预期抗菌药物使用。

临床怎么用

  • 作者认为应设计更好的系统,而非因不依从归咎个人。
  • 作者认为每个学科都应在设计干预措施时采用系统思维。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sepsis is a leading cause of preventable death and requires timely antimicrobial treatment to reduce mortality. Despite extensive sepsis management guidelines, high-income countries continue to have considerable rates of sepsis mortality, indicating a gap between guideline quality, usability, and practical application. Simultaneously, the rise of antimicrobial resistance threatens the efficacy of antimicrobial therapies for infection control, underscoring the tension between sepsis management and antimicrobial stewardship. This Personal View explores how system factors, such as people, environments, tools, technologies, and tasks, influence the sepsis-antimicrobial stewardship tension. With the Systems Engineering Initiative for Patient Safety, we use a case study to highlight how organisational pressures, inadequate diagnostic tools, and sociocultural factors drive the gap between work-as-imagined and work-as-done. These latent safety risks that impede guideline adherence and contribute to unintended antimicrobial use highlight the need to design better systems, not blame individuals for non-compliance. We argue that addressing sepsis and antimicrobial resistance requires a holistic systems approach and that every discipline, including policy makers, clinicians, researchers, and drug developers, should adopt systems thinking in the design of interventions intended to address this problem. This shift is essential to ensuring effective care for patients today while safeguarding the effectiveness of antimicrobials tomorrow.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lounsbury O, O'Hara J, Brent AJ, et al. Designing better systems to navigate the sepsis-antimicrobial stewardship tension. Lancet Infect Dis. 2025. PMID: 40222374. doi:10.1016/S1473-3099(25)00119-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。